Pages that link to "Q34852161"
Jump to navigation
Jump to search
The following pages link to Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease (Q34852161):
Displaying 31 items.
- Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence? (Q22251219) (← links)
- Omega-3 fatty acids: potential role in the management of early Alzheimer's disease (Q24595490) (← links)
- Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention (Q26997377) (← links)
- Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a review (Q26998916) (← links)
- Maintenance of synaptic stability requires calcium-independent phospholipase A₂ activity (Q27027705) (← links)
- Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better? (Q28397361) (← links)
- Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex (Q33813237) (← links)
- Group VIA Ca2 -independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death (Q33886495) (← links)
- Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system (Q34099708) (← links)
- Phospholipase A2 - nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairment (Q34630947) (← links)
- The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease (Q35327219) (← links)
- Calcium-independent phospholipases A2 and their roles in biological processes and diseases. (Q35994344) (← links)
- Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD. (Q36188186) (← links)
- Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment (Q37054001) (← links)
- Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease (Q37559812) (← links)
- Emerging cognitive enhancing drugs (Q37601479) (← links)
- Phospholipases A2 and inflammatory responses in the central nervous system (Q37621283) (← links)
- Exercise facilitates the action of dietary DHA on functional recovery after brain trauma (Q37634130) (← links)
- Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. (Q38598430) (← links)
- Regulation of Calcium-Independent Phospholipase A2 Expression by Adrenoceptors and Sterol Regulatory Element Binding Protein-Potential Crosstalk Between Sterol and Glycerophospholipid Mediators (Q38931646) (← links)
- Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer's disease (Q40217838) (← links)
- Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease (Q40261286) (← links)
- Association between nerve growth factor gene polymorphism and executive dysfunction in Japanese patients with early-stage Alzheimer's disease and amnestic mild cognitive impairment (Q48678719) (← links)
- Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study (Q49031432) (← links)
- Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease (Q50041775) (← links)
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients (Q50588053) (← links)
- Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele (Q51029552) (← links)
- Role of Calcium Independent Phospholipase A2 in Maintaining Mitochondrial Membrane Potential and Preventing Excessive Exocytosis in PC12 Cells (Q82663288) (← links)
- A subchronic toxicity study, preceded by an in utero exposure phase, with refined arachidonic acid-rich oil (RAO) derived from Mortierella alpina XM027 in rats (Q86100947) (← links)
- Nicotinamide attenuates the decrease in dendritic spine density in hippocampal primary neurons from 5xFAD mice, an Alzheimer's disease animal model (Q89599644) (← links)
- Recent Preclinical Insights Into the Treatment of Chronic Traumatic Encephalopathy (Q98288607) (← links)